Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-4_07-cv-05702/USCOURTS-cand-4_07-cv-05702-54/pdf.json

Nature of Suit Code: 190
Nature of Suit: Other Contract Actions
Cause of Action: 15:1 Antitrust Litigation

---

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

2355825 STIPULATION REGARDING PRE-TRIAL EXCHANGES AND TRIAL PROCEDURES

IRELL & MANELLA LLP 

Alexander F. Wiles (CA 73596) awiles@irell.com 

Brian Hennigan (CA 86955) bhennigan@irell.com 

Trevor V. Stockinger (CA 226359) tstockinger@irell.com 

S. Albert Wang (CA 250163) awang@irell.com 

1800 Avenue of the Stars, Suite 900 

Los Angeles, California 90067-4276 

Telephone: (310) 277-1010 

Facsimile: (310) 203-7199 

ARNOLD & PORTER LLP 

Kenneth A. Letzler (Admitted Pro Hac Vice) Kenneth_Letzler@aporter.com 

Daniel S. Pariser (Admitted Pro Hac Vice) Daniel_Pariser@aporter.com 

Barbara H. Wootton (Admitted Pro Hac Vice) Barbara Wootton@aporter.com 

555 Twelfth Street, NW Washington, DC 20004-1206 

Telephone: (202) 942-5000 

Facsimile: (202) 942-5999 

Attorneys for Plaintiff 

GlaxoSmithKline 

[ADDITIONAL ATTORNEYS ON SIGNATURE PAGE] 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

OAKLAND DIVISION 

SMITHKLINE BEECHAM CORPORATION 

d/b/a/ GLAXOSMITHKLINE, 

Plaintiff, 

 v. 

ABBOTT LABORATORIES, 

Defendant. 

)

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

Case No. C07-5702 (CW) 

Related per November 19, 2007 Order to 

Case No. C-04-1511 (CW)

STIPULATION REGARDING PRETRIAL EXCHANGES AND TRIAL 

PROCEDURES 

Date: N/A 

Time: N/A 

Courtroom: N/A 

Judge: Hon. Claudia Wilken 

(Caption continued on next page.) 

Case 4:07-cv-05702-CW Document 322 Filed 01/06/11 Page 1 of 4
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

2355825 STIPULATION REGARDING PRE-TRIAL EXCHANGES AND TRIAL PROCEDURES

SAFEWAY INC., et al

Plaintiff, 

 v. 

ABBOTT LABORATORIES , 

Defendant. 

)

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

Case No. C07-5470 (CW)

Related per November 19, 2007 Order to Case No. C-04-1511 (CW)

STIPULATION REGARDING PRETRIAL EXCHANGES AND TRIAL 

PROCEDURES 

Date: N/A 

Time: N/A 

Courtroom: N/A 

Judge: Hon. Claudia Wilken 

MEIJER, INC. & MEIJER DISTRIBUTION, 

INC., et al., 

Plaintiff, 

 v. 

ABBOTT LABORATORIES , 

Defendant. 

 

)

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

)

Case No. C07-5985 (CW) 

Related per November 3, 2007 Order to Case No. C-04-1511 (CW)

STIPULATION REGARDING PRETRIAL EXCHANGES AND TRIAL 

PROCEDURES 

Date: N/A 

Time: N/A 

Courtroom: N/A 

Judge: Hon. Claudia Wilken 

RITE AID CORPORATION, et al., 

Plaintiff, 

 v. 

ABBOTT LABORATORIES , 

Defendant. 

 

)

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

)

Case No. C07-6120 (CW) 

Related per December 5, 2007 Order to 

Case No. C-04-1511 (CW)

STIPULATION REGARDING PRETRIAL EXCHANGES AND TRIAL 

PROCEDURES 

Date: N/A 

Time: N/A 

Courtroom: N/A 

Judge: Hon. Claudia Wilken 

Case 4:07-cv-05702-CW Document 322 Filed 01/06/11 Page 2 of 4
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

2355825 

- 1 - 

STIPULATION REGARDING PRE-TRIAL EXCHANGES AND TRIAL PROCEDURES

WHEREAS, the Direct Purchaser plaintiffs,1 plaintiff SmithKline Beecham d/b/a 

GlaxoSmithKline, and defendant Abbott Laboratories (“Abbott”) seek to enter into agreements to 

increase the efficiency of, and better manage, pre-trial exchanges and disclosures in Case Nos. 

C07-5702 (CW), 07-5470 (CW), 07-5985 (CW), and 07-6120 (CW) (the “related cases”); 

WHEREAS, the parties believe the following arrangements would be convenient and 

efficient for not only the parties but for the Court as well; 

IT IS HEREBY STIPULATED AND AGREED: 

1. Any party planning to use a demonstrative at trial will disclose a copy of that 

demonstrative to the opposing party no less than 72 hours before that demonstrative’s anticipated 

use at trial. After a demonstrative has been disclosed, no changes to that demonstrative are 

permitted absent consent or Court approval other than non-substantive corrections (e.g., 

corrections of typographic errors). Magnifications of quotations from or other portions of 

documents disclosed on exhibit lists, callouts of quotations or other portions of those documents, 

or similar emphasis of quotations or other portions of those documents, do not constitute 

demonstratives and will not be subject to this disclosure agreement. 

2. All motions and related documents required under Local Rule 79-5 to support the 

sealing of confidential documents submitted during the course of the trial will not be due from the 

submitting party until 30 days after the conclusion of trial. If a party has submitted information 

designated confidential by another party, the declaration from the designating party required by 

Local Rule 79-5(d) to support the sealing of that information will be not be due until 40 days after 

the conclusion of trial. 

IT IS SO STIPULATED, THROUGH COUNSEL OF RECORD: 

/s/ Alexander F. Wiles Alexander F. Wiles 

IRELL & MANELLA LLP 

1800 Avenue of the Stars, Suite 900 

Los Angeles, CA 90067-4276 

Counsel for GSK

 /s/ Stephanie S. McCallum 

Stephanie S. McCallum 

WINSTON & STRAWN LLP 

35 W. Wacker Drive 

Chicago, IL 60601 

Counsel for Abbott Laboratories

 1

 Plaintiffs in Case Nos. 07-5470 (CW), 07-5985 (CW), and 07-6120 (CW). 

Case 4:07-cv-05702-CW Document 322 Filed 01/06/11 Page 3 of 4
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

2355825 

- 2 - 

STIPULATION REGARDING PRE-TRIAL EXCHANGES AND TRIAL PROCEDURES

/s/ Scott E. Perwin 

Scott E. Perwin 

KENNY NACHWALTER, PA 

1100 Miami Center 

201 South Biscayne Blvd. 

Miami, FL 33131 

Counsel for Safeway Inc., et al.

/s/ Daniel Simons 

Daniel Simons 

BERGER & MONTAGUE, P.C. 

1622 Locust Street 

Philadelphia, PA 19103 

Counsel for the District Purchaser Class 

/s/ Monica L. Rebuck 

Monica L. Rebuck 

HANGLEY ARONCHICK SEGAL 

& PUDLIN 

30 N. Third Street, Suite 700 

Harrisburg, PA 17101 

Counsel for Rite Aid Corp., et al.

Pursuant to General Order No. 45, Section X, I attest under penalty of perjury that 

concurrence in the filing of this document has been obtained from the above signatories. 

Dated: January 1, 2011 /s/ S. Albert Wang

 S. Albert Wang 

IRELL & MANELLA LLP 

Counsel for GSK 

PURSUANT TO STIPULATION, PARAGRAPH 1 IS SO ORDERED; PARAGRAPH 2 IS 

REJECTED AS INFEASIBLE. 

Dated: 1/6/2011 

 

Judge Claudia Wilken 

United States District Court 

Case 4:07-cv-05702-CW Document 322 Filed 01/06/11 Page 4 of 4